Do you have the same question? Follow this Question
Mar 06, 2026 - 11:22 AM
We’ve provided several answers to questions related to Kisqali (Ribociclib) , see some other helpful Q&A related to this product.
Question: What is this medication used for?
Answer: This medication is used in combination with other drugs to treat certain types of breast cancer. This treatment can help slow cancer progression by targeting the way cancer cells grow and divide.
Question: What is the active ingredient in this medication?
Answer: The active ingredient is ribociclib. Knowing the active ingredient helps when discussing allergies, potential side effects, and alternative treatments.
Question: What is the ATC code for this medication?
Answer: The ATC code is L01EF02. The ATC (Anatomical Therapeutic Chemical) code classifies drugs based on their therapeutic use, which is valuable for healthcare professionals and patients researching treatment options.
Question: What is the licensing authority for this medication?
Answer: This medication is licensed by the US FDA (United States Food and Drug Administration). FDA approval means the medication has been evaluated for safety and efficacy, offering reassurance to patients.
Question: What is the protein binding percentage for this medication?
Answer: The protein binding is 70%. Protein binding affects how much of the drug is available in your bloodstream, impacting both effectiveness and potential interactions with other medications.
Question: What is the chemical formula for the active ingredient?
Answer: The chemical formula for ribociclib, the active ingredient, is C23H30N8O. Knowing the chemical formula is valuable for those interested in the molecular structure or when comparing similar medications.
Question: How many tablets come in a pack for the 200mg strength?
Answer: The 200mg strength is available in a pack containing 21 tablets. This specific quantity supports a typical 21-day treatment cycle, making it easier to follow your prescribed regimen.
